Pathogenesis of Dengue Haemorrhagic Fever and Its Impact on Case Management. (21st October 2012)

• Record Type: Journal Article
• Authors: Sellahewa, Kolitha H.
• Other Names: Bologna R. Academic Editor.; Favory R. Academic Editor.; Sawanyawisuth K. Academic Editor.
• Is Part Of: ISRN infectious diseases. Volume 2013(2013)
• Publication Date: 2012-10-21
• Subjects: Communicable diseases -- Periodicals; 616.9
• DOI: 10.5402/2013/571646
• Languages: English
• ISSNs: 2090-8725

Abstract

Abstract : Plasma leakage and intrinsic coagulopathy are the pathological hall marks in dengue haemorrhagic fever (DHF). Viral virulence, infection enhancing antibodies, cytokines and chemical mediators in the setting of intense immune activation are the key players implicated in the pathogenesis of DHF; the exact nature of which is yet to be fully understood. The pathophysiological changes the attended clinical features of plasma leakage necessitate recognition of changing physiological parameters for the early recognition of plasma leakage and appropriate fluid therapy. On the other hand, the changes in the haematological indices resulting from coagulopathy can tempt the clinician to initiate other modalities of therapy. A clearer understanding of the pathogenesis of DHF and the appreciation that both of these fundamental pathological changes share common pathogenic mechanisms would facilitate the appropriateness of management decisions and the early recognition of severe disease. Thus, thrombocytopaenia, reduced fibrinogen, and prolonged partial thromboplastin time early in the disease course connoted severe disease and attended plasma leakage rather than clinical bleeding. The detection of plasma cytokine profile by a multiple bead immunoassay could also complement clinical parameters in predicting severe disease early in the disease course. Thus, MIP- β indicates good prognosis while IFN- γ portends severe disease.